87 participants
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-28
- Start Date:
- 2024-10-12
- Completion:
- 2025-12-20
Conditions
- IgA Nephropathy (IgAN)
Interventions
- DRUG
No Results Yet